Proleukin launched?

See the DrugPatentWatch profile for Proleukin

When was Proleukin first launched?

Proleukin (aldesleukin) is a brand name for interleukin-2 (IL-2). The provided information does not include a launch date.

What does “Proleukin launched” usually refer to?

People may mean one of these events:
- The original market introduction of Proleukin by the manufacturer
- The first regulatory approval date in a specific country (often the U.S. FDA)
- The start of commercial availability in a particular indication (such as metastatic renal cell carcinoma or metastatic melanoma)

Which indication was Proleukin launched for?

The provided information does not specify any indications tied to the launch.

Who made Proleukin and where was it first approved?

The provided information does not mention the manufacturer or the first country/agency that approved it.

If you meant patent/marketing exclusivity timing, which country?

Launch timing for market exclusivity and patent horizons depends on jurisdiction (e.g., U.S. vs. EU vs. Japan). The provided information does not include these details.

What I need to answer precisely

Share either:
- The year or country you’re referring to, or
- A link or excerpt about the “Proleukin launched” claim you saw,

and I’ll pinpoint the exact launch/approval date and context.